Business Description
Clearbridge Health Ltd
ISIN : SG1EB6000000
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.75 | |||||
Debt-to-EBITDA | -0.24 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -8.75 | |||||
Beneish M-Score | -8.57 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -33.5 | |||||
3-Year EPS without NRI Growth Rate | -73.8 | |||||
3-Year Book Growth Rate | -45.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.83 | |||||
9-Day RSI | 59.29 | |||||
14-Day RSI | 52.6 | |||||
6-1 Month Momentum % | -27.28 | |||||
12-1 Month Momentum % | -33.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.73 | |||||
Quick Ratio | 1.68 | |||||
Cash Ratio | 0.91 | |||||
Days Inventory | 20.57 | |||||
Days Sales Outstanding | 37.71 | |||||
Days Payable | 33.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | 26.6 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 53.05 | |||||
Operating Margin % | -121.05 | |||||
Net Margin % | -280.24 | |||||
FCF Margin % | -35.87 | |||||
ROE % | -104.45 | |||||
ROA % | -70.18 | |||||
ROIC % | -32.95 | |||||
ROC (Joel Greenblatt) % | -1381.5 | |||||
ROCE % | -81.76 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.4 | |||||
PB Ratio | 0.44 | |||||
EV-to-EBIT | -0.3 | |||||
EV-to-EBITDA | -0.31 | |||||
EV-to-Revenue | 0.88 | |||||
EV-to-FCF | -2.45 | |||||
Earnings Yield (Greenblatt) % | -333.33 | |||||
FCF Yield % | -92.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Clearbridge Health Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil S$) | 11.49 | ||
EPS (TTM) (S$) | -0.029 | ||
Beta | 1.89 | ||
Volatility % | 46.3 | ||
14-Day RSI | 52.6 | ||
14-Day ATR (S$) | 0.000605 | ||
20-Day SMA (S$) | 0.003772 | ||
12-1 Month Momentum % | -33.33 | ||
52-Week Range (S$) | 0.002 - 0.011111 | ||
Shares Outstanding (Mil) | 1,115.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Clearbridge Health Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Clearbridge Health Ltd Stock Events
Event | Date | Price(S$) | ||
---|---|---|---|---|
No Event Data |
Clearbridge Health Ltd Frequently Asked Questions
What is Clearbridge Health Ltd(SGX:1H3)'s stock price today?
When is next earnings date of Clearbridge Health Ltd(SGX:1H3)?
Does Clearbridge Health Ltd(SGX:1H3) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |